Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Polymorphisms in receptors involved in opsonic and non-opsonic phagocytosis and the risk of infection in oncohematological patients.

Herrero-Sánchez MC, Angomás EB, de Ramón C, Tellería JJ, Corchete LA, Alonso S, Ramos MDC, Peñarrubia MJ, Márquez S, Fernández N, García Frade LJ, Sánchez Crespo M.

Infect Immun. 2018 Oct 1. pii: IAI.00709-18. doi: 10.1128/IAI.00709-18. [Epub ahead of print]

PMID:
30275011
2.

Targeting of PI3K/AKT/mTOR pathway to inhibit T cell activation and prevent graft-versus-host disease development.

Herrero-Sánchez MC, Rodríguez-Serrano C, Almeida J, San Segundo L, Inogés S, Santos-Briz Á, García-Briñón J, Corchete LA, San Miguel JF, Del Cañizo C, Blanco B.

J Hematol Oncol. 2016 Oct 20;9(1):113.

3.

Effect of mTORC1/mTORC2 inhibition on T cell function: potential role in graft-versus-host disease control.

Herrero-Sánchez MC, Rodríguez-Serrano C, Almeida J, San-Segundo L, Inogés S, Santos-Briz Á, García-Briñón J, SanMiguel JF, Del Cañizo C, Blanco B.

Br J Haematol. 2016 Jun;173(5):754-68. doi: 10.1111/bjh.13984. Epub 2016 Feb 23.

PMID:
26914848
4.

Profound blockade of T cell activation requires concomitant inhibition of different class I PI3K isoforms.

Blanco B, Herrero-Sánchez MC, Rodríguez-Serrano C, Sánchez-Barba M, Del Cañizo MC.

Immunol Res. 2015 Jun;62(2):175-88. doi: 10.1007/s12026-015-8648-y.

PMID:
25869396

Supplemental Content

Loading ...
Support Center